HealthEquity, Inc. (HQY): Price and Financial Metrics
HQY Price/Volume Stats
| Current price | $78.18 | 52-week high | $88.26 |
| Prev. close | $79.10 | 52-week low | $61.81 |
| Day low | $76.85 | Volume | 567,700 |
| Day high | $79.11 | Avg. volume | 621,584 |
| 50-day MA | $76.44 | Dividend yield | N/A |
| 200-day MA | $78.09 | Market Cap | 6.80B |
HQY Stock Price Chart Interactive Chart >
HealthEquity, Inc. (HQY) Company Bio
HealthEquity Inc. provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company was founded in 2002 and is based in Draper, Utah.
Latest HQY News From Around the Web
Below are the latest news stories about HEALTHEQUITY INC that investors may wish to consider to help them evaluate HQY as an investment opportunity.
3 Reasons to Hold Zimmer Biomet (ZBH) Stock in Your PortfolioZimmer Biomet's (ZBH) focus on emerging markets raises optimism about the stock. |
Does HealthEquity (HQY) Have the Potential to Rally 31.37% as Wall Street Analysts Expect?The consensus price target hints at a 31.4% upside potential for HealthEquity (HQY). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term. |
3 Amazing Health Service Stocks to Brave "Labordemic" in 2024Here are the three stocks, MEDP, ELV and HQY, which have the potential to shield your portfolio from the impact of healthcare staffing challenges in 2024. |
5 MedTech Stocks Poised to Continue Their Winning Streaks in 2024Stocks like DexCom Inc. (DXCM), Integer Holdings (ITGR), Penumbra (PEN), Haemonetics (HAE), Health Equity (HAE) and are likely to continue their strong performance in 2024. |
McKesson (MCK) Announces Availability of PNH's FDA-Approved DrugThe availability of the FDA-approved drug via McKesson's (MCK) independent specialty pharmacy is expected to give patients more treatment options for PNH. |
HQY Price Returns
| 1-mo | -5.42% |
| 3-mo | -5.32% |
| 6-mo | -1.52% |
| 1-year | 7.61% |
| 3-year | 19.78% |
| 5-year | 43.34% |
| YTD | 17.92% |
| 2023 | 7.56% |
| 2022 | 39.33% |
| 2021 | -36.54% |
| 2020 | -5.89% |
| 2019 | 24.17% |
Continue Researching HQY
Want to see what other sources are saying about Healthequity Inc's financials and stock price? Try the links below:Healthequity Inc (HQY) Stock Price | Nasdaq
Healthequity Inc (HQY) Stock Quote, History and News - Yahoo Finance
Healthequity Inc (HQY) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...